HTG Molecular Diagnostics, Inc.(HTGM)

Description: HTG Molecular Diagnostics, Inc. develops and markets a technology platform that facilitates the routine use of complex molecular profiling. The company's HTG Edge platform consists of instrumentation, consumables, and software analytics that are used in sample profiling applications, including tumor profiling, molecular diagnostic testing, and biomarker development. The HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology comprising HTG Edge Immuno-oncology Assay, HTG Edge FGFR Expression Assay, HTG Edge DLBCL Cell of Origin Assay, HTG EdgeSeq microRNA Whole-transcriptome Assay, HTG Edge Top Oncogene Assay, and HTG Edge DMPK Assay. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States; and through distributors or sales agents in parts of Europe, India, and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.

---

Keywords: Medicine Biotechnology Biology Tumor Drug Development Biomarkers Molecular Diagnostics Assay Microrna Oncogene Software Analytics

---

Home Page: www.htgmolecular.com

HTGM Technical Analysis

3430 East Global Loop
Tucson, AZ 85706
United States
Phone: 877 289 2615

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)